These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 7895883

  • 1. In vivo assessment of an animal model of diabetic cataract: medical intervention studies.
    Joon TL, Foo K, Panagiotopoulos S, Jerums G, Taylor HR.
    Dev Ophthalmol; 1994; 26():57-62. PubMed ID: 7895883
    [No Abstract] [Full Text] [Related]

  • 2. Cataract prevention in diabetic Octodon degus with Pfizer's sorbinil.
    Datiles MB, Fukui H.
    Curr Eye Res; 1989 Mar; 8(3):233-7. PubMed ID: 2523284
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of aldose reductase by Aegle marmelos and its protective role in diabetic cataract.
    Sankeshi V, Kumar PA, Naik RR, Sridhar G, Kumar MP, Gopal VV, Raju TN.
    J Ethnopharmacol; 2013 Aug 26; 149(1):215-21. PubMed ID: 23827758
    [Abstract] [Full Text] [Related]

  • 4. Diabetic cataracts in animal models: prevention and reversibility with aldose reductase inhibitors.
    Kador PF, Akagi Y, Kinoshita JH.
    Diabet Med; 1985 May 26; 2(3):194-6. PubMed ID: 2952419
    [No Abstract] [Full Text] [Related]

  • 5. [Inhibition effect of epalrestat on rat lens osmotic expansion].
    Ji LX, Shen N, Li CN, Liu Q, Huan Y, Shen ZF.
    Yao Xue Xue Bao; 2009 Oct 26; 44(10):1107-11. PubMed ID: 20055132
    [Abstract] [Full Text] [Related]

  • 6. Delaying of cataract through intervention of Hemidesmus indicus in STZ induced diabetic rats.
    Tirumani P, Venu S, Sridhar G, Praveen Kumar M, Rajashekhar AV, Naga Raju T.
    Nat Prod Res; 2018 Jun 26; 32(11):1295-1298. PubMed ID: 28580798
    [Abstract] [Full Text] [Related]

  • 7. A novel high resolution in vivo digital imaging system for the evaluation of experimental cataract in diabetic rats.
    Kametaka S, Kasahara T, Ueo M, Takenaka M, Saito M, Sakamoto K, Nakahara T, Ishii K.
    J Pharmacol Sci; 2008 Jan 26; 106(1):144-51. PubMed ID: 18187926
    [Abstract] [Full Text] [Related]

  • 8. KIOM-79 inhibits aldose reductase activity and cataractogenesis in Zucker diabetic fatty rats.
    Kim J, Kim CS, Sohn E, Lee YM, Kim JS.
    J Pharm Pharmacol; 2011 Oct 26; 63(10):1301-8. PubMed ID: 21899546
    [Abstract] [Full Text] [Related]

  • 9. [The role of lens epithelium in cataract formation in diabetic rats].
    Fan W, Yan M, Hu Y, Li G.
    Hua Xi Yi Ke Da Xue Xue Bao; 1998 Jun 26; 29(2):185-8. PubMed ID: 10684012
    [Abstract] [Full Text] [Related]

  • 10. Anti-cataract Effect of Resveratrol in High-Glucose-Treated Streptozotocin-Induced Diabetic Rats.
    Higashi Y, Higashi K, Mori A, Sakamoto K, Ishii K, Nakahara T.
    Biol Pharm Bull; 2018 Jun 26; 41(10):1586-1592. PubMed ID: 30270328
    [Abstract] [Full Text] [Related]

  • 11. Raman spectroscopic study of the effect of aldose reductase inhibitor on experimental diabetic cataract.
    Nozawa H, Yaginuma T, Mizuno A.
    Nippon Ganka Gakkai Zasshi; 1988 Jan 26; 92(1):194-201. PubMed ID: 3133929
    [No Abstract] [Full Text] [Related]

  • 12. Quercetin inhibited epithelial mesenchymal transition in diabetic rats, high-glucose-cultured lens, and SRA01/04 cells through transforming growth factor-β2/phosphoinositide 3-kinase/Akt pathway.
    Du L, Hao M, Li C, Wu W, Wang W, Ma Z, Yang T, Zhang N, Isaac AT, Zhu X, Sun Y, Lu Q, Yin X.
    Mol Cell Endocrinol; 2017 Sep 05; 452():44-56. PubMed ID: 28501572
    [Abstract] [Full Text] [Related]

  • 13. A new approach against sugar cataract through aldose reductase inhibitors.
    Banditelli S, Boldrini E, Vilardo PG, Cecconi I, Cappiello M, Dal Monte M, Marini I, Del Corso A, Mura U.
    Exp Eye Res; 1999 Nov 05; 69(5):533-8. PubMed ID: 10548473
    [Abstract] [Full Text] [Related]

  • 14. Therapeutic potential of resveratrol in diabetic complications: In vitro and in vivo studies.
    Ciddi V, Dodda D.
    Pharmacol Rep; 2014 Oct 05; 66(5):799-803. PubMed ID: 25149983
    [Abstract] [Full Text] [Related]

  • 15. Effect of carnosine, aminoguanidine, and aspirin drops on the prevention of cataracts in diabetic rats.
    Yan H, Guo Y, Zhang J, Ding Z, Ha W, Harding JJ.
    Mol Vis; 2008 Oct 05; 14():2282-91. PubMed ID: 19081783
    [Abstract] [Full Text] [Related]

  • 16. Inhibitory effect of lycopene on cataract development in galactosemic rats.
    Pollack A, Madar Z, Eisner Z, Nyska A, Oren P.
    Metab Pediatr Syst Ophthalmol (1985); 2008 Oct 05; 19-20():31-6. PubMed ID: 11548783
    [Abstract] [Full Text] [Related]

  • 17. Zopolrestat prevention of proteinuria, albuminuria and cataractogenesis in diabetes mellitus.
    Beyer-Mears A, Mistry K, Diecke FP, Cruz E.
    Pharmacology; 1996 May 05; 52(5):292-302. PubMed ID: 8807673
    [Abstract] [Full Text] [Related]

  • 18. Altering the course of cataracts in diabetic rats.
    Fukushi S, Merola LO, Kinoshita JH.
    Invest Ophthalmol Vis Sci; 1980 Mar 05; 19(3):313-5. PubMed ID: 6766909
    [Abstract] [Full Text] [Related]

  • 19. The effect of aldose reductase and its inhibition on sugar cataract formation.
    Kador PF, Akagi Y, Kinoshita JH.
    Metabolism; 1986 Apr 05; 35(4 Suppl 1):15-9. PubMed ID: 3083204
    [Abstract] [Full Text] [Related]

  • 20. Effect of instillation of aldose reductase inhibitor FR74366 on diabetic cataract.
    Ao S, Kikuchi C, Ono T, Notsu Y.
    Invest Ophthalmol Vis Sci; 1991 Nov 05; 32(12):3078-83. PubMed ID: 1834606
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.